References
- Roberts NA Martin JA Kinchington D Rational design of peptide-based HIV proteinase inhibitors Science 1990 248 4953 358 361 2183354
- Blundell T Sibanda BL Pearl L Three-dimensional structure, specificity and catalytic mechanism of renin Nature 1983 304 5923 273 275 6346109
- von Itzstein M Wu WY Kok GB Rational design of potent sialidase-based inhibitors of influenza virus replication Nature 1993 363 6428 418 423 8502295
- Centers for Disease Control and Prevention Cancer data and Statistics (webpage on the Internet) Available from http://www.cdc.gov/cancer/dcpc/data/ Accessed December 5, 2013
- Fortune JM Osheroff N Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice Prog Nucleic Acid Res Mol Biol 2000 64 221 253 10697411
- Su QG Liu Y Cai YC Sun YL Wang B Xian LJ Anti-tumour effects of xanthone derivatives and the possible mechanisms of action Invest New Drugs 2011 29 6 1230 1240 20577894
- Yadav DK Meena A Srivastava A Chanda D Khan F Chattopadhyay SK Development of QSAR model for immunomodulatory activity of natural coumarinolignoids Drug Des Devel Ther 2010 4 173 186
- Pommier Y Leo E Zhang H Marchand C DNA topoisomerases and their poisoning by anticancer and antibacterial drugs Chem Biol 2010 17 5 421 433 20534341
- Pouli N Marakos P Fused xanthone derivatives as antiproliferative agents Anticancer Agents Med Chem 2009 9 1 77 98 19149484
- Kuete V Wabo HK Eyong KO Anticancer activities of six selected natural compounds of some Cameroonian medicinal plants PLoS One 2011 6 8 e21762 21886765
- Koizumi Y Tomoda H Kumagai A Zhou XP Koyota S Sugiyama T Simaomicin α, a polycyclic xanthone, induces G1 arrest with suppression of retinoblastoma protein phosphorylation Cancer Sci 2009 100 2 322 326 19077005
- Woo S Kang DH Nam JM Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues Eur J Med Chem 2010 45 9 4221 4228 20619511
- Woo S Jung J Lee C Kwon Y Na Y Synthesis of new xanthone analogues and their biological activity test – cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study Bioorg Med Chem Lett 2007 17 5 1163 1166 17194586
- Cho HJ Jung MJ Woo S New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers Bioorg Med Chem 2010 18 3 1010 1017 20093033
- Gao XM Yu T Cui MZ Identification and evaluation of apoptotic compounds from Garcinia oligantha Bioorg Med Chem Lett 2012 22 6 2350 2353 22365754
- Jun KY Lee EY Jung MJ Synthesis, biological evaluation, and molecular docking study of 3-(3′-heteroatom substituted-2′-hydroxy-1′-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor Eur J Med Chem 2011 46 6 1964 1971 21419530
- Qidwai T Yadav DK Khan F Dhawan S Bhakuni RS QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum Curr Pharm Des 2012 18 37 6133 6154 22670592
- Lipinski CA Lombardo F Dominy BW Feeney PJ Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Deliv Rev 2001 46 1–3 3 26 11259830
- Trott O Olson AJ AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J Comput Chem 2010 31 2 455 461 19499576
- Boda K Seidel T Gasteiger J Structure and reaction based evaluation of synthetic accessibility J Comput Aided Mol Des 2007 21 6 311 325 17294248
- Ee GC Lim CK Rahmat A Lee HL Cytotoxic activities of chemical constituents from Mesua daphnifolia Trop Biomed 2005 22 2 99 102 16883274
- Lynch T Price A The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects Am Fam Physician 2007 76 3 391 396 17708140